NL174142C - METHOD FOR PREPARING A THERAPEUTIC PREPARATION CONTAINING A PROSTAGLANDINE DERIVATIVE AND METHOD FOR PREPARING A PROSTAGLANDINE DERIVATIVE SUITABLE FOR IT - Google Patents

METHOD FOR PREPARING A THERAPEUTIC PREPARATION CONTAINING A PROSTAGLANDINE DERIVATIVE AND METHOD FOR PREPARING A PROSTAGLANDINE DERIVATIVE SUITABLE FOR IT

Info

Publication number
NL174142C
NL174142C NL7115049A NL7115049A NL174142C NL 174142 C NL174142 C NL 174142C NL 7115049 A NL7115049 A NL 7115049A NL 7115049 A NL7115049 A NL 7115049A NL 174142 C NL174142 C NL 174142C
Authority
NL
Netherlands
Prior art keywords
prostaglandine
preparing
derivative
preparation containing
therapeutic preparation
Prior art date
Application number
NL7115049A
Other languages
Dutch (nl)
Other versions
NL7115049A (en
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NL7115049A publication Critical patent/NL7115049A/xx
Application granted granted Critical
Publication of NL174142C publication Critical patent/NL174142C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
    • C07C35/27—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system containing six carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26—Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
NL7115049A 1970-11-02 1971-11-02 METHOD FOR PREPARING A THERAPEUTIC PREPARATION CONTAINING A PROSTAGLANDINE DERIVATIVE AND METHOD FOR PREPARING A PROSTAGLANDINE DERIVATIVE SUITABLE FOR IT NL174142C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8630370A 1970-11-02 1970-11-02
US16744671A 1971-07-29 1971-07-29

Publications (2)

Publication Number Publication Date
NL7115049A NL7115049A (en) 1972-05-04
NL174142C true NL174142C (en) 1984-05-01

Family

ID=26774597

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7115049A NL174142C (en) 1970-11-02 1971-11-02 METHOD FOR PREPARING A THERAPEUTIC PREPARATION CONTAINING A PROSTAGLANDINE DERIVATIVE AND METHOD FOR PREPARING A PROSTAGLANDINE DERIVATIVE SUITABLE FOR IT

Country Status (6)

Country Link
BE (1) BE774709A (en)
DE (1) DE2154309C3 (en)
FR (1) FR2112390B1 (en)
GB (1) GB1324737A (en)
HK (1) HK57378A (en)
NL (1) NL174142C (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971826A (en) * 1972-07-13 1976-07-27 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandins
ES416865A1 (en) * 1972-07-13 1976-03-01 Pfizer 15-substituted-omega-pentanorprostaglandins
US3974213A (en) * 1972-07-13 1976-08-10 Pfizer Inc. 13,14-Dihydro-15-substituted-ω-pentanorprostaglandins
US4011262A (en) * 1972-07-13 1977-03-08 Pfizer Inc. 13,14-Dihydro-15-substituted-ω-pentanorprostaglandins of the two series
DD118856A5 (en) * 1972-11-08 1976-03-20
US3966795A (en) * 1973-05-21 1976-06-29 The Upjohn Company 5-Oxa-11-deoxyphenyl- and phenoxy-substituted prostaglandin F1.sub.α analogs
US3968144A (en) * 1973-05-21 1976-07-06 The Upjohn Company 5-Oxa-11-deoxy phenyl- and phenoxy-substituted prostalandin E1 analogs
US4005115A (en) * 1974-01-07 1977-01-25 The Upjohn Company Phenyl-substituted prostaglandin-A type analogs
US4001286A (en) * 1974-01-07 1977-01-04 The Upjohn Company Phenyl-substituted prostaglandin-β-type anologs
US4328355A (en) * 1976-12-27 1982-05-04 G. D. Searle & Co. Prostaglandin derivatives having aryl, hydroxyl, and alkynyl functions in one side chain
US6420422B1 (en) 1987-09-18 2002-07-16 Sucampo Pharmaceuticals, Inc. Ocular hypotensive agents
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ATE101342T1 (en) 1988-09-06 1994-02-15 Kabi Pharmacia Ab PROSTAGLAND INDIVIDUALS FOR THE TREATMENT OF GREEN STAR OR OCULAR HYPERTENSION.
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5223537A (en) * 1991-07-23 1993-06-29 Kabi Pharmacia Ab Method and composition for treatment of gastric and duodenal disorders
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins

Also Published As

Publication number Publication date
FR2112390B1 (en) 1975-08-01
DE2154309C3 (en) 1981-06-19
BE774709A (en) 1972-05-02
DE2154309A1 (en) 1972-05-04
HK57378A (en) 1978-10-06
NL7115049A (en) 1972-05-04
FR2112390A1 (en) 1972-06-16
DE2154309B2 (en) 1980-11-06
GB1324737A (en) 1973-07-25

Similar Documents

Publication Publication Date Title
NL170143C (en) PROCESS FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH ANTI-IGNITION ACTIVITY, AND METHOD FOR PREPARING POLYARYLIMIDAZOLES SUITABLE FOR IT.
NL158072B (en) PROCESS FOR PREPARING A COSMETIC PREPARATION.
NL174142C (en) METHOD FOR PREPARING A THERAPEUTIC PREPARATION CONTAINING A PROSTAGLANDINE DERIVATIVE AND METHOD FOR PREPARING A PROSTAGLANDINE DERIVATIVE SUITABLE FOR IT
NL171145C (en) METHOD FOR PREPARING A LANTHANIDE COMPOUND
NL177568C (en) METHOD FOR PREPARING A SKIN TREATMENT AGENT
NL173053C (en) METHOD FOR PREPARING A PEPTIDE, AND METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION SUITABLE FOR DIAGNOSTIC PURPOSES.
NL172240C (en) METHOD FOR PREPARING PTERIDINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS.
NL167440C (en) PROCESS FOR PREPARING AN EVOMONOSIDE DERATIVE AND A THERAPEUTIC PREPARATION CONTAINING A SUCH DERIVATIVE.
NL166471C (en) METHOD FOR PREPARING A THERAPEUTIC PREPARATION AND METHOD FOR PREPARING A SUITABLE BENZOPHEN DERIVATIVE
NL172657C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION AND PROCESS FOR PREPARING USEFUL PYRAZOLOOL3.4-BŸ-PYRIDINE DERIVATIVES
NL167323C (en) PROCESS FOR PREPARING A PSYCHOPHARMACOLOGICAL PREPARATION.
NL176678C (en) METHOD FOR PREPARING A THERAPEUTIC PREPARATION CONTAINING A LINCOMYCIN-RELATED COMPOUND, PREPARED PRODUCT AND METHOD FOR PREPARING LINCOMYCIN-RELATED COMPOUNDS.
NL166018C (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION, AND FOR PREPARATIONS PREPARED USING THIS PROCESS AND METHOD FOR PREPARING SUITABLE COMPOUNDS.
NL164552C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION; FORMED PHARMACEUTICAL PREPARATION; METHOD FOR PREPARING MEDICINAL COMPOUNDS.
NL178591C (en) METHOD FOR PREPARING A 6-DESOXYTETRACYCLINE, AND METHOD FOR PREPARING OR MANUFACTURING A THERAPEUTIC PREPARATION CONTAINING SUCH TETRACYCLINE
NL161150C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT, AND FORMED MEDICINAL PRODUCT AND METHOD FOR PREPARING A BENZOFURAN COMPOUND
NL171269C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT AND METHOD FOR PREPARING ANTIMYCOTIC AND FUNGITOXICALLY ACTIVE IMIDAZOL-1-YL-DIPHENYL METHANE DERIVATIVES
NL169179C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT WITH BETA-ADRENERGICALLY STIMULATING EFFECT, FORMED MEDICINAL PRODUCT AND METHOD FOR PREPARING UREIDOBENZYL COMPOUNDS
NL177279C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT
NL162903C (en) PROCESS FOR PREPARING A DERIVATIVE OF 3,4-DIHYDRO-ISOCHINOLINE.
NL176366C (en) PROCESS FOR PREPARING 4,9,11-TRIESTEROID COMPOUNDS, METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION AND FORMED PHARMACEUTICAL PREPARATION.
NL168228B (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANTIBACTERIAL ACTION, AND METHOD FOR PREPARING A 7-ACYLAMINOCEPHALOSPORANIC ACID DERIVATIVE.
NL146693B (en) PROCESS FOR PREPARING A MUSKITE CONTROL AGENT.
NL180588C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANTIBACTERIAL ACTION, AND METHOD FOR PREPARING A 7-Alpha-METHOXY-7-BETA-ACETAMIDOCEPHALOSPORINE DERIVATIVE.
NL171777B (en) METHOD FOR PREPARING A VACCINE OF RUBELLAVIRUS.